Skip to content
★ Sign in to follow
JW

Jacob Waugh

Executive
Revance Therapeutics, Inc.
Total declarations
16
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (8 ops.)
€2.0M

Latest filing published 21 May 2015 for Revance Therapeutics, Inc., €73k.

Insider track record

Disclosed buys
0
Disclosed sells
8
Signal history

No signal scores available.

Jacob Waugh: trading record in brief

Jacob Waugh appears in our data through filings on Revance Therapeutics, Inc. shares, published by SEC (Form 4). In total, 16 filings cover trades dated from 19 May 2014 to 19 May 2015.

Every open-market trade on record is a sale: 8 sales worth €2.0M. Outside the open market, there are 3 share grants and 5 option exercises.

The record was last updated on 21 May 2015 with a share grant (€73k) in Revance Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Jacob Waugh

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations16 total

16 of 16 declarations